FDA Adds Strict Safety Warnings on Arthritis Drugs from Pfizer, AbbVie, and Lilly

The FDA has added boxed warnings on the labels of Pfizer’s Xeljanz, Eli Lilly’s Olumiant, and AbbVie’s Rinvoq, JAK inhibitors used to treat conditions such as rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis, Reuters reports. The serious warnings flag risks of cardiovascular death and stroke in high-risk patients who are aged 50 and above and are current or past smokers.

The added warning follows the agency’s review of results from a February trial of Xeljanz, which showed increased risks of serious heart problems and cancer in some patients.

Read more

Are you looking for data-driven marketing for your law firm?

As a full-service agency, CAMG handles everything from marketing and creative to the support your law firm needs to operate campaigns at the maximum efficiency.
The CAMG Legal Marketing Index®

Significantly Increase your Marketing Success, on us.

CAMG’s Legal Marketing Index® offers unprecedented reporting and comprehensive analysis of real-time data. Because more intelligent marketing decisions mean a better ROI.
Scroll to Top